Fortress Biotech takes out $60M loan for debt purposes; Entasis pulls in $25M private placement for PhIII trial
Fortress Biotech, the incubator at the center of a stock market scandal two summers ago, is taking out a loan to refinance existing debt. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
